Dysregulation of the endogenous cannabinoid system following opioid exposure

Area of Science:

• Neuroscience
• Pharmacology
• Addiction Medicine

Background:

• Opioid-related deaths and overdoses are at record-high levels in the United States.
• Novel neurobiological targets for opioid use disorder (OUD) treatment are urgently needed.
• The endocannabinoid system (ECS) interacts closely with the endogenous opioid system, indicating therapeutic potential for OUD.

Purpose of the Study:

• To review clinical and preclinical literature on the dysregulation of the ECS following opioid exposure.
• To examine evidence of ECS dysregulation across diverse study types, exposure, and measurement protocols.
• To summarize findings on the dysregulation of ECS components in specific brain regions.

Main Methods:

• Systematic review of existing clinical and preclinical research.
• Analysis of studies investigating the effects of opioids on the endocannabinoid system.
• Examination of data across various experimental designs and measurement techniques.

Main Results:

• Preclinical research indicates that opioids can disrupt region-specific ECS components.
• The existing literature presents heterogeneous and sometimes contradictory findings regarding ECS dysregulation.
• Variability in methodologies across studies may contribute to the inconsistent results.

Conclusions:

• The endocannabinoid system presents potential therapeutic targets for treating opioid use disorder.
• Opioid exposure appears to dysregulate ECS components in a region-specific manner, though findings are inconsistent.
• Further research employing standardized methodologies is required to establish definitive conclusions on opioid effects on the ECS.